A monthly deep dive into the most influential and practice-shaping publications in Gastroenterology. Each episode breaks down key studies, highlights clinical implications, and offers clear, evidence-based insights for busy clinicians, trainees, and researchers. Whether it’s landmark trials, emerging therapies, or updated guidelines, this podcast brings the latest GI literature to life—helping listeners stay current, think critically, and apply new knowledge at the bedside.
Gastroenterology April 2026 Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease
This study evaluates how effectively a specific blood biomarker, phosphatidylethanol (PEth), can forecast severe liver complications in individuals at risk for alcohol-related liver disease. While traditional noninvasive tests primarily measure existing liver scarring or fibrosis, this research demonstrates that tracking PEth levels provides a distinct, independent layer of prognostic data regarding a patient's future health. Although the predictive accuracy of a single PEth measurement fades over time, the study highlights that monitoring changes in alcohol intakethrough repeated testing is a powerful tool for identifying those most likely to experience hepatic failure. Ultimately, the findings suggest that integrating this chemical marker with standard physical assessments offers a more comprehensive view of disease progression than using either method in isolation.
24 Mar 2026
Gastroenterology April 2026 Genetic Risk of Inflammatory Bowel Disease Is Associated With Disease Course Severity
This study investigates whether a person’s inherited predisposition to inflammatory bowel disease (IBD) also determines how aggressively the condition will progress. By analyzing thousands of patients, researchers found that individuals with a higher genetic burden faced significantly more hospitalizations, surgeries, and a greater need for intensive drug therapies. While the severity of Crohn’s disease was often linked to how much of the digestive tract was affected, ulcerative colitis showed a more direct shared genetic architecture between developing the disease and experiencing its most debilitating symptoms. Ultimately, the findings suggest that the same DNA markers used to predict the risk of IBD can also serve as a vital tool for forecasting a patient's long-term clinical outcome.
24 Mar 2026
Gastroenterology April 2026 Faecalibacterium prausnitzii Induces an Anti-inflammatory Response and a Metabolic Reprogramming in Human Monocytes
This study explores how a common gut bacterium, Faecalibacterium prausnitzii, protects human health by directly influencing immune cells to reduce inflammation. Researchers discovered that this specific microbe triggers a dose-dependent production of IL10, a vital anti-inflammatory signal, within monocytes located in both the blood and the intestines. Unlike other bacteria, F. prausnitzii achieves this effect by rewiring the metabolic pathways of these cells, specifically by shifting their reliance toward mitochondrial respiration. By providing a mechanistic explanation for how this bacterium stabilizes the immune system, the text highlights its potential as a therapeutic tool for treating inflammatory bowel disease
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
1 ratings
Contact Gastroenterology Abstracts On The Go
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Gastroenterology Abstracts On The Go?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
